Fletcher CV - Search Results

1

Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir.

Dunn DL, Mayoral JL, Gillingham KJ, Loeffler CM, Brayman KL, Kramer MA, Erice A, Balfour HH Jr, Fletcher CV, Bolman RM 3rd, et al. Dunn DL, et al. Among authors: fletcher cv. Transplantation. 1991 Jan;51(1):98-106. doi: 10.1097/00007890-199101000-00015. Transplantation. 1991. PMID: 1846255 Clinical Trial.

2

Cytomegalovirus infections in the immunocompromised transplant patient. Prevention of cytomegalovirus disease with oral acyclovir.

Balfour HH Jr, Fletcher CV, Dunn D. Balfour HH Jr, et al. Among authors: fletcher cv. Transplant Proc. 1991 Apr;23(2 Suppl 1):17-9. Transplant Proc. 1991. PMID: 1647558 Clinical Trial. No abstract available.

3

Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients.

Fletcher CV, Englund JA, Edelman CK, Gross CR, Dunn DL, Balfour HH Jr. Fletcher CV, et al. Antimicrob Agents Chemother. 1991 May;35(5):938-43. doi: 10.1128/AAC.35.5.938. Antimicrob Agents Chemother. 1991. PMID: 1649575 Free PMC article. Clinical Trial.

4

Evaluation of ganciclovir for cytomegalovirus disease.

Fletcher CV, Balfour HH Jr. Fletcher CV, et al. DICP. 1989 Jan;23(1):5-12. doi: 10.1177/106002808902300101. DICP. 1989. PMID: 2541566 Review.

5

Pharmacokinetics and safety of high-dose oral acyclovir for suppression of cytomegalovirus disease after renal transplantation.

Fletcher CV, Chinnock BJ, Chace B, Balfour HH Jr. Fletcher CV, et al. Clin Pharmacol Ther. 1988 Aug;44(2):158-63. doi: 10.1038/clpt.1988.131. Clin Pharmacol Ther. 1988. PMID: 2840229

6

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

Henry K, Cantrill H, Fletcher C, Chinnock BJ, Balfour HH Jr. Henry K, et al. Am J Ophthalmol. 1987 Jan 15;103(1):17-23. doi: 10.1016/s0002-9394(14)74163-7. Am J Ophthalmol. 1987. PMID: 3026186

7

Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.

Erice A, Jordan MC, Chace BA, Fletcher C, Chinnock BJ, Balfour HH Jr. Erice A, et al. JAMA. 1987 Jun 12;257(22):3082-7. JAMA. 1987. PMID: 3035246

8

Acyclovir therapy in neonates.

Englund JA, Fletcher CV, Balfour HH Jr. Englund JA, et al. Among authors: fletcher cv. J Pediatr. 1991 Jul;119(1 Pt 1):129-35. doi: 10.1016/s0022-3476(05)81053-4. J Pediatr. 1991. PMID: 2066845

9

Continuous infusion of high-dose acyclovir for serious herpesvirus infections.

Fletcher CV, Englund JA, Bean B, Chinnock B, Brundage DM, Balfour HH Jr. Fletcher CV, et al. Antimicrob Agents Chemother. 1989 Aug;33(8):1375-8. doi: 10.1128/AAC.33.8.1375. Antimicrob Agents Chemother. 1989. PMID: 2552909 Free PMC article.

10

Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS.

Balfour HH Jr, Fletcher CV, Erice A, Henry WK, Acosta EP, Smith SA, Holm MA, Boivin G, Shepp DH, Crumpacker CS, Eaton CA, Martin-Munley SS. Balfour HH Jr, et al. Among authors: fletcher cv. Antimicrob Agents Chemother. 1996 Dec;40(12):2721-6. doi: 10.1128/AAC.40.12.2721. Antimicrob Agents Chemother. 1996. PMID: 9124829 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

228 results

Search Page